IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

RP Management, LLC

Q3 2023 Holdings

Filed 2023-11-13 | 3 holdings | $103.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biohaven LTD(BHVN)COMG1110E107$76.4M2,936,50773.7%
Biocryst Pharmaceuticals Inc(BCRX)COM09058V103$27.2M3,846,15426.3%
Viracta Therapeutics IncCOM92765F108$3.8K3,7000.0%